CFLAR and cancer: A likely cause for the downregulation of c-FLIPS in these cancer cells is that c-FLIPL is hetero-dimerized with c-FLIPS in vivo and that the binding of DTX1 to c-FLIPL induces the degradation of c-FLIPL-c-FLIPS dimers.